Connor McGregor, Brett Favre, and the Celebrity Ibogaine Moment
Connor McGregor. Brett Favre. Keith Jardine. Marcus Luttrell in the Oval Office. The elite athletes and combat operators who broke the ibogaine taboo in public and created the cultural permission structure that made Trump’s executive order politically possible.
Americans for Ibogaine and Bryan Hubbard: The Kentucky Story That Led to the Oval Office
Bryan Hubbard tried to get Kentucky to spend $42 million of opioid settlement money on ibogaine research in 2023. He lost that fight. Two years later he was standing in the Oval Office next to Trump and Rogan. The coalition-building story, and why Americans for Ibogaine should lead the Ameen Alai clemency push next.
The 2024 Stanford Study: Magnesium-Ibogaine for Veterans With TBI (What It Proved)
Thirty US Special Operations veterans with traumatic brain injury. One magnesium-ibogaine session. Eighty-eight percent reduction in PTSD symptoms. The Stanford Nature Medicine paper that rewrote the political conversation on plant medicine.
Ibogaine vs Methadone vs Suboxone: Why Addiction Medicine Is About to Be Disrupted
Methadone replaces heroin with heroin-lite. Suboxone replaces opioids with another opioid. Both are maintenance businesses dressed up as medicine. Ibogaine, the compound Trump’s executive order just fast-tracked, resets the receptor system in a single night and reports outcomes neither can touch.
Right to Try and Ibogaine: What Trump’s Executive Order Actually Unlocks
Trump’s executive order does five specific things. It does not legalize ibogaine. A clear-eyed breakdown of what actually changes: Right to Try pathway, National Priority Voucher review, investigational new drug clearance, $50M state research, and the realistic timeline for legal US clinics.
Guru Ameen Starts 48 Months for Ibogaine — And Within 6 Months, RFK Jr. Will Make Everything He Did Legal
Ameen got 48 months. The federal judge declared ibogaine ‘more dangerous than fentanyl’ on the sentencing record. The same month Texas launched a $50 million ibogaine research program and Netflix dropped a documentary showing Navy SEALs credit the molecule with saving their lives. My prediction, on the record: within six months, the Trump administration issues executive action. And then we fight for the pardon.
They’re Trying to Crucify Guru Ameen for Healing People: Stanford Just Proved He Was Right
Fifteen months after I first wrote about my friend Guru Ameen’s federal case, the ‘resulting in death’ charge has collapsed — exactly as I predicted. Meanwhile, Stanford just published an 88% PTSD reduction result with ibogaine in combat veterans, and an unprecedented political coalition is forming. The dam is about to break.
The Price of Being First: Tony Huge, the Peptide Industry, and the Pattern of Punished Pioneers
Tony Huge helped build the modern peptide industry — and paid for being early. The pattern repeats across medical history: Semmelweis committed to an asylum for handwashing, Galileo tried for heresy, Barry Marshall drinking bacteria to prove ulcers are infectious, Prusiner called a heretic for twenty years before the Nobel. Eight YouTube channels and twenty+ Instagram accounts removed. This article is the record.
Trump Just Legalized the Road to Ibogaine Approval. Ameen Alai Is Still in Prison for It.
On April 18, 2026, Trump signed an executive order fast-tracking FDA review of ibogaine for addiction and PTSD, with Rogan, RFK Jr., and Americans for Ibogaine CEO Bryan Hubbard in the Oval Office. FDA Commissioner Makary confirmed approval could come in 60 days. Meanwhile Ameen Alai sits in federal prison serving 48 months for distributing the exact compound the federal government now calls a national priority. The case for clemency writes itself.
FDA Energy Supplement Warnings: Fear-Mongering or Science?
The FDA’s latest gas station supplement warning ignores dosage science and individual variation. Here’s what the research actually shows about energy ingredients.